The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Novartis, which spends up to $400m (£247.9m) a year on external lawyers, previously had a 15-firm global panel.
Many of the previous members, including Cravath Swaine & Moore, Kaye Scholer, Wachtell Lipton Rosen & Katz and WilmerHale, have been transferred to the US panel.
Following a review by the company’s UK legal head, the first UK panel includes A&O, Arnold & Porter, Freshfields, Covington & Burling, Linklaters and SJ Berwin. Linklaters will deal mainly with M&A and antitrust matters, while SJ Berwin will handle patent litigation.
Werlen has spent three years overhauling Novartis’s 250-lawyer team, dividing it into practice areas and appointing global heads of the different groups, including M&A, antitrust, litigation and capital markets.